BackCybin Overview

Cybin Total Assets

Track Cybin's total assets ($180M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$181.25M
↓ 30.93% YoYΔ $-81.14M vs prior year quarter

Peer trimmed avg / median

Loading

Cybin Total Assets History

Loading

Cybin vs. peers: Total Assets Comparison

Loading

Cybin Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cybin (CYBN) FAQ

Cybin (CYBN) currently reports a total assets of $180M as of September 2025. That compares with $260M in the prior-year period — down 30.9% year over year. Use the charts on this page to explore Cybin's total assets history and peer comparisons.

Cybin's total assets decreased from $260M to $180M — a 30.9% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cybin reported $180M in total assets as of September 2025. That compares with $260M in the prior-year period — down 30.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cybin, and consider following CYBN for alerts when major investors trade the stock.

Cybin is classified in the Healthcare sector. On total assets, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYBN with unrelated industries.